Comparative Analysis of Outcomes Among Patients Treated With Xeljanz vs Biologics

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
To compare rheumatoid arthritis (RA) patient characteristics, adherence, and costs between patients treated with tofacitinib (IR, XR and combined groups) to patients treated with each of the bDMARDs.
Epistemonikos ID: c89b43bafbcc88932508919a6b5884c079e067d2
First added on: May 22, 2024